ERMP1, a novel potential oncogene involved in UPR and oxidative stress defense, is highly expressed in human cancer
Alberto Grandi(Toscana Life Sciences), Renata Grifantini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Paola Chiarugi(University of Florence), Luigi Terracciano(Humanitas University), Aurélien Lacombe(Inserm), Chaojun Song(Air Force Medical University), Matteo Parri(University of Florence), Elisa De Camilli(European Institute of Oncology), Susanna Campagnoli, Alice Santi(European Society for Sexual Medicine), Paolo Sarmientos, Giuseppe Viale(University of Milan), Serenella Castori-Eppenberger(University Hospital of Basel), Boquan Jin(Air Force Engineering University), Piero Pileri
Cited by 33
Related Papers
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer (Unabridged Version)
|Archives of Pathology & Laboratory Medicine|2010|1.1k
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Archives of Pathology & Laboratory Medicine|2010|898
HER2-Low Breast Cancer: Pathological and Clinical Landscape
|Journal of Clinical Oncology|2020|801